{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T02:12:02Z","timestamp":1768788722185,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s11936-006-0054-2","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T18:54:40Z","timestamp":1180896880000},"page":"334-344","source":"Crossref","is-referenced-by-count":7,"title":["Goals and guidelines for treating hypertension in a patient with heart failure"],"prefix":"10.1007","volume":"8","author":[{"given":"Douglas S.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramachandran S.","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"54_CR1","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0735-1097(00)00582-9","volume":"35","author":"JS Gottdiener","year":"2000","unstructured":"Gottdiener JS, Arnold AM, Aurigemma GP, et al: Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000, 35:1628\u20131637.","journal-title":"J Am Coll Cardiol"},{"key":"54_CR2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archinte.159.11.1197","volume":"159","author":"WB Kannel","year":"1999","unstructured":"Kannel WB, D\u2019Agostino RB, Silbershatz H, et al: Profile for estimating risk of heart failure. Arch Intern Med 1999, 159:1197\u20131204.","journal-title":"Arch Intern Med"},{"key":"54_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-138-1-200301070-00006","volume":"138","author":"AW Haider","year":"2003","unstructured":"Haider AW, Larson MG, Franklin SS, Levy D: Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003, 138:10\u201316.","journal-title":"Ann Intern Med"},{"key":"54_CR4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9343(99)00126-6","volume":"106","author":"YT Chen","year":"1999","unstructured":"Chen YT, Vaccarino V, Williams CS, et al: Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 1999, 106:605\u2013612.","journal-title":"Am J Med"},{"key":"54_CR5","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.553370","volume":"112","author":"SA Hunt","year":"2005","unstructured":"Hunt SA, Abraham WT, Chin MH, et al: ACC\/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154-e235.","journal-title":"Circulation"},{"key":"54_CR6","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","volume":"362","author":"F Turnbull","year":"2003","unstructured":"Turnbull F: Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003, 362:1527\u20131535. An excellent systematic review of antihypertensive medication regimens and cardiovascular outcomes including heart failure.","journal-title":"Lancet"},{"key":"54_CR7","doi-asserted-by":"crossref","unstructured":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [no authors listed]. JAMA 2002, 288:2981\u20132997.","DOI":"10.1001\/jama.288.23.2981"},{"key":"54_CR8","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","volume":"283","author":"ALLHAT Collaborative Research Group","year":"2000","unstructured":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group [no authors listed]. JAMA 2000, 283:1967\u20131975.","journal-title":"JAMA"},{"key":"54_CR9","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy D, Larson MG, Vasan RS, et al: The progression from hypertension to congestive heart failure. JAMA 1996, 275:1557\u20131562.","journal-title":"JAMA"},{"key":"54_CR10","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199705083361903","volume":"336","author":"RS Vasan","year":"1997","unstructured":"Vasan RS, Larson MG, Benjamin EJ, et al: Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997, 336:1350\u20131355.","journal-title":"N Engl J Med"},{"key":"54_CR11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/archinte.164.13.1389","volume":"164","author":"DT Ko","year":"2004","unstructured":"Ko DT, Hebert PR, Coffey CS, et al: Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. Arch Intern Med 2004, 164:1389\u20131394.","journal-title":"Arch Intern Med"},{"key":"54_CR12","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/jama.290.19.2581","volume":"290","author":"DS Lee","year":"2003","unstructured":"Lee DS, Austin PC, Rouleau JL, et al: Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003, 290:2581\u20132587.","journal-title":"JAMA"},{"key":"54_CR13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","volume":"47","author":"CW Yancy","year":"2006","unstructured":"Yancy CW, Lopatin M, Stevenson LW, et al: Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006, 47:76\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"54_CR14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/eurheartj\/ehi696","volume":"27","author":"R Silva de","year":"2006","unstructured":"de Silva R, Nikitin NP, Witte KK, et al: Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 2006, 27:569\u2013581.","journal-title":"Eur Heart J"},{"key":"54_CR15","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206\u20131252.","journal-title":"Hypertension"},{"key":"54_CR16","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, et al: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903\u20131913.","journal-title":"Lancet"},{"key":"54_CR17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/euhj.1998.1472","volume":"20","author":"L Solang","year":"1999","unstructured":"Solang L, Malmberg K, Ryden L: Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J 1999, 20:789\u2013795.","journal-title":"Eur Heart J"},{"key":"54_CR18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461\u2013470.","journal-title":"Ann Intern Med"},{"key":"54_CR19","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, et al: Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005, 67:2089\u20132100.","journal-title":"Kidney Int"},{"key":"54_CR20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","volume":"113","author":"HL Hillege","year":"2006","unstructured":"Hillege HL, Nitsch D, Pfeffer MA, et al: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006, 113:671\u2013678.","journal-title":"Circulation"},{"key":"54_CR21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00005344-200311000-00007","volume":"42","author":"C Gaudio","year":"2003","unstructured":"Gaudio C, Ferri FM, Giovannini M, et al: Comparative effects of irbesartan versus amlodipine on left ventricular mass index in hypertensive patients with left ventricular hypertrophy. J Cardiovasc Pharmacol 2003, 42:622\u2013628.","journal-title":"J Cardiovasc Pharmacol"},{"key":"54_CR22","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","volume":"105","author":"J Diez","year":"2002","unstructured":"Diez J, Querejeta R, Lopez B, et al: Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002, 105:2512\u20132517.","journal-title":"Circulation"},{"key":"54_CR23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/01.hjh.0000160222.17092.b8","volume":"23","author":"R Muller-Brunotte","year":"2005","unstructured":"Muller-Brunotte R, Edner M, Malmqvist K, Kahan T: Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy. J Hypertens 2005, 23:633\u2013640.","journal-title":"J Hypertens"},{"key":"54_CR24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","volume":"327","author":"The SOLVD Investigators","year":"1992","unstructured":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators [no authors listed]. N Engl J Med 1992, 327:685\u2013691.","journal-title":"N Engl J Med"},{"key":"54_CR25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1054\/jcaf.2002.128871","volume":"8","author":"HH Chen","year":"2002","unstructured":"Chen HH, Lainchbury JG, Senni M, et al: Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail 2002, 8:279\u2013287.","journal-title":"J Card Fail"},{"key":"54_CR26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","volume":"362","author":"S Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K, et al: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARMPreserved Trial. Lancet 2003, 362:777\u2013781. An important, large randomized trial of pharmacologic therapy in patients with heart failure and preserved LV systolic function. Demonstrated a reduction in heart failure morbidity with active treatment.","journal-title":"Lancet"},{"key":"54_CR27","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.CIR.82.6.2254","volume":"82","author":"M Packer","year":"1990","unstructured":"Packer M: Calcium channel blockers in chronic heart failure. The risks of \"physiologically rational\" therapy. Circulation 1990, 82:2254\u20132257.","journal-title":"Circulation"},{"key":"54_CR28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.hco.0000143392.80705.a2","volume":"19","author":"D Fernando","year":"2004","unstructured":"Fernando D, Garasic J: Percutaneous intervention for renovascular disease: rationale and patient selection. Curr Opin Cardiol 2004, 19:582\u2013588.","journal-title":"Curr Opin Cardiol"},{"key":"54_CR29","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.jacc.2003.11.050","volume":"43","author":"CE Buller","year":"2004","unstructured":"Buller CE, Nogareda JG, Ramanathan K, et al: The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol 2004, 43:1606\u20131613. Provides a descriptive analysis of renovascular disease epidemiology in a cardiology referral sample.","journal-title":"J Am Coll Cardiol"},{"key":"54_CR30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.jhh.1000599","volume":"12","author":"J Webster","year":"1998","unstructured":"Webster J, Marshall F, Abdalla M, et al: Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998, 12:329\u2013335.","journal-title":"J Hum Hypertens"},{"key":"54_CR31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/heart.83.2.152","volume":"83","author":"CG Missouris","year":"2000","unstructured":"Missouris CG, Belli AM, MacGregor GA: \"Apparent\" heart failure: a syndrome caused by renal artery stenoses. Heart 2000, 83:152\u2013155.","journal-title":"Heart"},{"key":"54_CR32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0140-6736(88)92668-2","volume":"2","author":"TG Pickering","year":"1988","unstructured":"Pickering TG, Herman L, Devereux RB, et al: Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet 1988, 2:551\u2013552.","journal-title":"Lancet"},{"key":"54_CR33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1191\/1358863x02vm456oa","volume":"7","author":"BH Gray","year":"2002","unstructured":"Gray BH, Olin JW, Childs MB, et al: Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med 2002, 7:275\u2013279.","journal-title":"Vasc Med"},{"key":"54_CR34","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/eurheartj\/ehi304","volume":"26","author":"R Silva de","year":"2005","unstructured":"de Silva R, Nikitin NP, Bhandari S, et al: Atherosclerotic renovascular disease in chronic heart failure: should we intervene? Eur Heart J 2005, 26:1596\u20131605. Well-written review of renovascular disease epidemology and management considerations in heart failure.","journal-title":"Eur Heart J"},{"key":"54_CR35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341:709\u2013717.","journal-title":"N Engl J Med"},{"key":"54_CR36","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, et al: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003, 348:1309\u20131321.","journal-title":"N Engl J Med"},{"key":"54_CR37","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","volume":"108","author":"B Pitt","year":"2003","unstructured":"Pitt B, Reichek N, Willenbrock R, et al: Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 2003, 108:1831\u20131838.","journal-title":"Circulation"},{"key":"54_CR38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.0000138680.89536.A9","volume":"110","author":"PM Mottram","year":"2004","unstructured":"Mottram PM, Haluska B, Leano R, et al: Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 2004, 110:558\u2013565.","journal-title":"Circulation"},{"key":"54_CR39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.HYP.0000036399.80194.D8","volume":"40","author":"AM Grandi","year":"2002","unstructured":"Grandi AM, Imperiale D, Santillo R, et al: Aldosterone antagonist improves diastolic function in essential hypertension. Hypertension 2002, 40:647\u2013652.","journal-title":"Hypertension"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-006-0054-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-006-0054-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-006-0054-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:30Z","timestamp":1559436990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-006-0054-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["54"],"URL":"https:\/\/doi.org\/10.1007\/s11936-006-0054-2","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}